YOLO vs. GNOM ETF Comparison
Comparison of AdvisorShares Pure Cannabis ETF (YOLO) to Global X Genomics & Biotechnology ETF (GNOM)
YOLO
AdvisorShares Pure Cannabis ETF
YOLO Description
Cannabis and its various applications have been used throughout human civilization for over 5,000 years. As society, business and regulatory landscapes evolve in the 21st century, the upside potential of cannabis as an emerging investment avenue has arrived. The portfolio manager believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities. The AdvisorShares Pure Cannabis ETF (Ticker: YOLO) became the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. The AdvisorShares Pure Cannabis ETF, or YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace.
Grade (RS Rating)
Last Trade
$2.61
Average Daily Volume
57,389
8
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.Grade (RS Rating)
Last Trade
$10.08
Average Daily Volume
43,573
40
Performance
| Period | YOLO | GNOM |
|---|---|---|
| 30 Days | -25.00% | -5.26% |
| 60 Days | -19.69% | -8.86% |
| 90 Days | -21.81% | -12.73% |
| 12 Months | -9.01% | -3.58% |
0 Overlapping Holdings
| Symbol | Grade | Weight in YOLO | Weight in GNOM | Overlap |
|---|
YOLO Underweight 40 Positions Relative to GNOM
| Symbol | Grade | Weight | |
|---|---|---|---|
| NTRA | B | -6.14% | |
| VCYT | B | -5.24% | |
| CRSP | D | -4.45% | |
| QGEN | D | -4.33% | |
| TECH | D | -4.3% | |
| A | D | -4.19% | |
| RNA | D | -4.17% | |
| ARWR | F | -4.07% | |
| BNTX | D | -3.99% | |
| ILMN | D | -3.99% | |
| LEGN | F | -3.96% | |
| BMRN | D | -3.88% | |
| SRPT | D | -3.7% | |
| RARE | D | -3.68% | |
| ALNY | D | -3.66% | |
| BEAM | D | -3.6% | |
| MRNA | F | -3.0% | |
| MYGN | F | -2.74% | |
| TXG | F | -2.72% | |
| NTLA | F | -2.69% | |
| CDNA | D | -2.27% | |
| RCKT | F | -2.24% | |
| GILD | C | -2.2% | |
| VRTX | F | -2.08% | |
| VIR | D | -1.22% | |
| MRVI | F | -1.15% | |
| PACB | F | -0.91% | |
| RGNX | F | -0.87% | |
| SGMO | C | -0.79% | |
| FLGT | F | -0.69% | |
| SANA | F | -0.62% | |
| VERV | F | -0.58% | |
| ALLO | F | -0.57% | |
| QURE | D | -0.52% | |
| EDIT | F | -0.4% | |
| PSTX | D | -0.36% | |
| CRBU | F | -0.33% | |
| TSVT | F | -0.3% | |
| LYEL | F | -0.29% | |
| SCLX | F | -0.01% |
YOLO: Top Represented Industries & Keywords
GNOM: Top Represented Industries & Keywords
Compare ETFs
